Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link | Zendy

Antonio Cicione | Zendy; Francesco Cantiello | Zendy; Cosimo De Nunzio | Zendy; Andrea Tubaro | Zendy; Rocco Damiano | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link

Author(s) -

Antonio Cicione,

Francesco Cantiello,

Cosimo De Nunzio,

Andrea Tubaro,

Rocco Damiano

Publication year - 2013

Publication title -

canadian urological association journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.477

H-Index - 38

eISSN - 1920-1214

pISSN - 1911-6470

DOI - 10.5489/cuaj.311

Subject(s) - concordance , medicine , prostatectomy , prostate cancer , biopsy , prostate biopsy , prostate , pathological , prostate specific antigen , urology , radiology , cancer

Biopsy Gleason score (GS), in combination with other clinical parameters, is important to take a therapeutic decision for patients with diagnosis of localized prostate cancer. However, preoperative GS is often upgraded after a radical prostatectomy. Increasing the amount of tissue in prostate biopsy may be a way to avoid this issue. We evaluate the influence of a larger biopsy needle size on the concordance between biopsy and pathological GS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research